Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02599220 · ClinicalTrials.gov registry record
Clinical Outcomes and Cost of Gram Negative Bacteremia
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT02599220: Completed study, sponsored by Duke University.
NCT02599220 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02599220 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
This study examines the clinical outcomes and healthcare costs associated with gram negative bacteremia at Duke University Medical Center from 2002-2015.
Primary Outcome
The investigators are measuring in-hospital mortality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2002-01 |
| Est. Completion | 2015-05 |
What the finished NCT02599220 record still lists
NCT02599220 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02599220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02599220 about?
NCT02599220 is a clinical study titled "Clinical Outcomes and Cost of Gram Negative Bacteremia". This study examines the clinical outcomes and healthcare costs associated with gram negative bacteremia at Duke University Medical Center from 2002-2015.
What is the current status of trial NCT02599220?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2002-01. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT02599220?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia